ACADIA Pharmaceuticals, Inc. (ACAD)
26.76
-0.68
(-2.48%)
USD |
NASDAQ |
Dec 08, 16:00
26.77
+0.01
(+0.04%)
Pre-Market: 08:45
ACADIA Pharmaceuticals EPS Diluted (Quarterly): 0.4206 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Vanda Pharmaceuticals, Inc. | -0.3822 |
| ADMA Biologics, Inc. | 0.1489 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| Amicus Therapeutics, Inc. | 0.0558 |
| ANI Pharmaceuticals, Inc. | 1.133 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 71.78M |
| Revenue (Quarterly) | 278.63M |
| Total Expenses (Quarterly) | 206.85M |
| Enterprise Value | 3.735B |
| Gross Profit Margin (Quarterly) | 92.23% |
| Profit Margin (Quarterly) | 25.76% |
| Earnings Yield | 5.81% |
| Operating Earnings Yield | 2.09% |
| Normalized Earnings Yield | 5.808 |